✍️ Trichometrics Editorial Team·🩺 Reviewed for medical accuracy
For informational purposes only — consult a healthcare provider before starting treatment.
Autoimmune Hair Loss

Alopecia Areata: Causes, Types & Treatment Options

Alopecia areata is an autoimmune condition where the immune system mistakenly attacks hair follicles. Understanding its types and triggers is the first step toward finding an effective treatment.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any treatment. Individual results may vary.

By the Numbers

Alopecia areata is more common than most people realize, and its prognosis varies widely depending on the extent of involvement.

~2%

of the global population is affected by alopecia areata at some point in their lifetime

, Safavi et al., 1995

50%

of those with limited patchy alopecia areata experience spontaneous remission within 1 year

<30

years old, the age at which most cases (66%) first present, with a peak in the second decade of life

Unlike androgenetic alopecia, alopecia areata is not caused by hormones or genetics alone, it is a T-cell mediated autoimmune attack on the hair follicle, which means the approach to treatment is fundamentally different.

Types of Alopecia Areata

The condition exists on a spectrum from limited patches to complete body hair loss. Each type has different treatment implications and prognosis.

Alopecia Areata

Most common

The most common form. Presents as one or more smooth, round or oval patches of hair loss on the scalp or other hair-bearing areas. Patches are typically coin-sized but can be larger.

Alopecia Totalis

~5% of cases

Complete loss of all hair on the scalp. Represents a more advanced form affecting approximately 5% of alopecia areata cases. The scalp appears smooth and bald, with no regrowth without treatment.

Alopecia Universalis

Rarest form

The most severe form, complete loss of hair on the scalp and entire body, including eyebrows, eyelashes, and body hair. Represents the far end of the spectrum and is significantly harder to treat.

Alopecia Ophiasis

Difficult to treat

A band-like pattern of hair loss along the sides and lower back of the scalp (resembling a snake). This pattern is particularly resistant to treatment and tends to have a worse prognosis than patchy alopecia areata.

Alopecia Areata vs. Pattern Baldness

These two conditions are frequently confused, but they have entirely different mechanisms, appearances, and treatments.

Alopecia Areata

  • Autoimmune cause, immune system attacks follicles
  • Sudden onset, often within weeks
  • Smooth, round or oval patches with well-defined edges
  • Can affect any hair-bearing area including beard and brows
  • Treated with immunosuppressants / JAK inhibitors

Androgenetic Alopecia (Pattern Baldness)

  • Hormonal / genetic cause. DHT-driven follicle miniaturization
  • Gradual onset over months or years
  • Diffuse thinning in predictable patterns (temples, crown)
  • Primarily affects scalp; beard rarely affected
  • Treated with minoxidil, finasteride, or hair transplant

Key diagnostic clue: Alopecia areata patches typically have an abrupt, sharp border and the scalp surface appears normal (no scaling). "Exclamation mark" hairs, short hairs that are narrower at the base than the tip, are a hallmark sign seen under a dermatoscope.

Known Triggers

While the underlying cause is autoimmune, certain factors can trigger or worsen episodes in predisposed individuals.

Psychological Stress

Major life stressors, anxiety, or emotional trauma can trigger or worsen episodes in genetically susceptible individuals by modulating the neuroimmune axis.

Illness or Infection

Viral infections and systemic illness can trigger immune activation. COVID-19 has been reported as a trigger in several documented case series (Kutlu & Metin, 2020).

Genetic Predisposition

Multiple HLA (human leukocyte antigen) gene variants increase susceptibility. Identical twin studies show ~55% concordance, confirming strong but incomplete genetic influence.

Autoimmune Co-conditions

Increased prevalence alongside thyroid disease, vitiligo, rheumatoid arthritis, and atopic dermatitis, suggesting shared immune dysregulation pathways.

Treatment Options

Treatment for alopecia areata targets the immune system rather than the hormone system. Options have expanded significantly with JAK inhibitor approvals.

Corticosteroids

First-Line

First-line treatment for most cases. Intralesional corticosteroid injections (triamcinolone acetonide) directly into patches suppress local immune activity and promote regrowth. Topical corticosteroids are an alternative for children or those who prefer to avoid injections.

JAK Inhibitors

FDA-Approved (Moderate-Severe)

A major breakthrough for moderate-to-severe alopecia areata. Baricitinib (Olumiant) and ritlecitinib (Litfulo) are FDA-approved specifically for alopecia areata. Clinical trials (King et al., 2022) showed up to 39% of patients achieved near-complete scalp hair coverage. These are oral medications that modulate the JAK-STAT signaling pathway.

Topical Immunotherapy (DPCP)

Specialist Treatment

Diphenylcyclopropenone (DPCP) applied to the scalp intentionally provokes a mild allergic reaction that appears to redirect the immune response away from hair follicles. Effective in approximately 40-60% of patients with extensive disease. Administered in specialist clinics.

Minoxidil (Adjunct)

Adjunct

While it does not address the underlying autoimmune cause, topical minoxidil (5%) can support regrowth and is often used alongside other treatments. It stimulates the growth phase and widens blood vessels supplying follicles.

Important: Because alopecia areata can relapse even after successful treatment, ongoing monitoring is essential. Tracking photo consistency over time helps you detect early relapse and respond quickly.

Track Your Hair Regrowth Over Time

Whether you're monitoring a patch for spontaneous regrowth or tracking treatment response, consistent photo analysis gives you and your dermatologist objective data to act on.

Start Tracking Free

Frequently Asked Questions

Is alopecia areata permanent?

Not necessarily. About 50% of people with mild alopecia areata (small patches) experience spontaneous regrowth within 1 year without any treatment. However, the condition is unpredictable, hair can regrow and then fall out again. Cases involving extensive scalp involvement (alopecia totalis) or body-wide hair loss (alopecia universalis) have lower rates of full spontaneous recovery. With modern treatments like JAK inhibitors, even severe cases can see significant regrowth.

Is alopecia areata genetic?

Genetics plays a significant role. Research published in Nature Genetics (2010) identified eight regions of the genome associated with alopecia areata, several of which overlap with other autoimmune conditions like rheumatoid arthritis and type 1 diabetes. If a first-degree relative has the condition, your risk is elevated. However, genetics is not destiny, many people with a family history never develop it, and many who develop it have no family history.

Can stress cause alopecia areata?

Stress is considered a potential trigger, not a direct cause. The immune system and nervous system are closely linked, and significant psychological or physical stress can trigger immune dysregulation in susceptible individuals. However, stress alone does not cause the condition, an underlying genetic predisposition is required. Managing stress through exercise, sleep, and mindfulness may help reduce flare frequency, but it is not a replacement for medical treatment.

Does alopecia areata spread across the whole scalp?

It can, but most cases remain as limited patchy loss. Around 5% of alopecia areata cases progress to alopecia totalis (complete scalp hair loss) or alopecia universalis (complete scalp and body hair loss). Factors associated with worse prognosis include onset in childhood, involvement of the hairline or nape, nail changes (pitting, ridging), or a long duration of the condition. Regular monitoring helps track whether patches are stable, shrinking, or expanding.